Medicare Enrolled
Dr. David Long, MD
Family Medicine · Lubbock, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Long from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Long?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Long
Dr. David Long is a family medicine specialist in Lubbock, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Long performed 1,792 Medicare services across 1,153 unique beneficiaries.
Between the years covered by Open Payments, Dr. Long received a total of $6,177 from 51 pharmaceutical and/or device companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Long is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in TX
$6,177 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,792
Medicare services
Top 16% in TX for family medicine
1,153
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~94 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $78 | $213 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
293 | $1 | $15 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
152 | $0 | $18 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
109 | $9 | $45 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
66 | $25 | $54 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
65 | $122 | $226 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
55 | $30 | $66 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $50 | $146 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
55 | $1 | $18 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
50 | $16 | $40 |
| Lincomycin antibiotic injection An injection of lincomycin hydrochloride, an antibiotic medication, administered in a dose of up to 300 mg. |
45 | $6 | $16 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
44 | $10 | $75 |
| Annual alcohol misuse screening, 5 to 15 minutes | 44 | $18 | $35 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
41 | $55 | $200 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
40 | $49 | $169 |
| Annual depression screening | 40 | $18 | $35 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
37 | $13 | $27 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
35 | $24 | $52 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $99 | $322 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
31 | $22 | $63 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
29 | $9 | $20 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
25 | $16 | $53 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
24 | $23 | $74 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
21 | $2 | $22 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
19 | $38 | $128 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
19 | $25 | $67 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
17 | $25 | $64 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
13 | $35 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $10 | $33 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,177
Total received (2018-2024)
Avg $882/year across 7 years
Top 10% in TX for family medicine
51
Companies
297
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,177 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,360
2023
$1,324
2022
$957
2021
$1,218
2020
$245
2019
$662
2018
$411
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$793
AstraZeneca Pharmaceuticals LP
$574
GlaxoSmithKline, LLC.
$408
Takeda Pharmaceuticals U.S.A., Inc.
$389
PFIZER INC.
$384
Biohaven Pharmaceutical Holding Company Ltd.
$374
AbbVie Inc.
$331
Biohaven Pharmaceuticals, Inc.
$330
Astellas Pharma US Inc
$248
Amgen Inc.
$228
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$186
Lilly USA, LLC
$185
Celgene Corporation
$164
Kowa Pharmaceuticals America, Inc.
$149
Novartis Pharmaceuticals Corporation
$114
ARBOR PHARMACEUTICALS, INC.
$107
Antares Pharma, Inc.
$95
Genentech USA, Inc.
$73
Novo Nordisk Inc
$71
Axsome Therapeutics, Inc.
$70
Myriad Women's Health, Inc.
$70
Janssen Pharmaceuticals, Inc
$56
Abbott Laboratories
$55
Aytu BioScience, Inc
$53
Almirall LLC
$50
Supernus Pharmaceuticals, Inc.
$46
Regeneron Healthcare Solutions, Inc.
$43
GENZYME CORPORATION
$41
Dexcom, Inc.
$41
DUSA Pharmaceuticals, Inc.
$37
Sun Pharmaceutical Industries Inc.
$37
PORTOLA PHARMACEUTICALS, LLC
$28
Acella Pharmaceuticals, LLC
$27
MAYNE PHARMA INC.
$25
LEO Pharma Inc.
$25
Horizon Therapeutics plc
$23
Bayer HealthCare Pharmaceuticals Inc.
$22
Inspire Medical Systems, Inc.
$22
Mayne Pharma Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Daiichi Sankyo Inc.
$17
Currax Pharmaceuticals LLC
$17
Lundbeck LLC
$17
Tactile Systems Technology Inc
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Janssen Biotech, Inc.
$14
MERZ NORTH AMERICA, INC.
$14
Merck Sharp & Dohme LLC
$13
Azurity Pharmaceuticals, Inc.
$13
VYNE Pharmaceuticals Inc.
$13
DERMIRA, INC.
$12
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
20% · AIRSUPRA · AMZEEQ · ANDEXXA · AREXVY · Aimovig · Auvelity · BELSOMRA · BEXSERO · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BREZTRI · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · COSENTYX · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLEXITOUCH · FREESTYLE LIBRE 3 · Finacea · Horizant · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INJECTAFER · INSPIRE · JARDIANCE · JUBLIA · KRYSTEXXA · Kerendia · Klisyri · LEVULAN KERASTICK · LINZESS · LIVALO · LO LOESTRIN FE · LUCEMYRA · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Livalo · MOUNJARO · MYRISK · NOCDURNA · NP Thyroid 60 · NURTEC ODT · Natesto · Otezla · Ozempic · PAXLOVID · PICATO · PREVNAR - 13 · PREVNAR 20 · QBREXZA · QULIPTA · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SPRAVATO · Seysara · TLANDO · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TRULANCE · Tuzistra XR · UBRELVY · VIBERZI · VRAYLAR · VYEPTI · Veozah · XIFAXAN · XYOSTED · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for family medicine in TX.
Equivalent to $345 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
111
Per 100K population
35.3
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Long is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement in the top 10% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Long experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Long performed 322 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Long receive payments from pharmaceutical companies?
Yes. Dr. Long received a total of $6,177 from 51 companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Long's costs compare to other family medicine physicians in Lubbock?
Dr. Long's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Long) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Lubbock
Browse family medicine physicians in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology